Introduction
A major mechanism of peripheral tolerance is suppression by regulatory T cells (Tregs) [1] . Several subtypes of Tregs have been defined based on the specific developmental processes involved in their generation. tTregs develop in the thymus and constitute approximately 5-10% of the total peripheral CD4 + T-cell population [1] . In contrast to tTregs, peripheral pTregs develop in peripheral lymphoid tissues from naïve CD4 + progenitors [2] . Several models have been proposed to explain how Tregs mediate suppression of T-cell activation [3] , including secretion of immunomodulatory cytokines [4, 5] and cell-to-cell contacts mediated by proteins such as CTLA-4 [6] or LAG-3 [7] . Regardless of which mechanisms are in play in any given context, the general outcome is an inhibition of proliferation and cytokine secretion. The molecular events that occur within the suppressed T cell that are ultimately responsible for inhibiting T-cell activation remain yet to be fully characterized.
The family of NFAT transcription factors is composed of four calcium-/calcineurin-regulated members, NFAT1-4, and a more distantly related NFAT5 [8] . In T cells, engagement of the TCR causes an elevation of intracellular calcium and the activation of calcineurin, which in turn dephosphorylates NFAT proteins leading to their nuclear translocation. NFAT proteins play major roles not only during T-cell activation but also in the induction of T-cell tolerance [9, 10] .
Here, we show that NFAT1 is required for effective Tregmediated suppression of T-helper (Th) cell activation. When T cells are activated in the presence of Tregs, they upregulate the NFAT1-dependent expression of Ikaros, which is necessary to achieve efficient suppression. Our results support a central role for NFAT1 in the regulation of Treg-mediated suppression of Th cells.
Results and Discussion

NFAT1-deficient T-helper cells show resistance to Treg-mediated suppression
Previous studies have shown that NFAT1 directs the expression of a specific set of genes responsible for the inhibition of Th1 cell effector functions in response to tolerizing stimuli [9] [10] [11] . To determine whether NFAT1 could regulate Treg-mediated suppression of effector Th-cell activation, we assessed the ability of Tregs to suppress NFAT1-deficient Th1 cells. Fig 1A) . Similar experiments using OT-II mice and Tregs from B6 Foxp3-RFP mice confirmed a significant decrease (~3-fold) in the susceptibility to Treg-mediated suppression in Th1 cells lacking NFAT1, ensuring that this was not a strain-specific effect (Fig 1B) . Tregs activate and expand when encountering their cognate antigen in vivo, and CD28 signaling appears crucial to maintain efficient Treg-suppressive activity [12, 13] . CD4 + CD25
+ T cells expanded for 1 week (Fig 1C) remained suppressive (Fig 1D) , but still failed to effectively inhibit Nfat1 À/À T cells ( Fig 1E) . As we had seen in anergic cells [10, 14] , effector NFAT1-deficient Th1 cells were less susceptible to Treg-mediated suppression. Further analyses using naïve CD4 + T cells confirmed that the requirement for NFAT1 also extended to this T-cell population (Fig 1F) . To confirm the NFAT1 requirement in vivo, we measured the ability of Tregs to suppress the homeostatic proliferation of CD4 + T cells transferred into lymphopenic hosts.
One week after adoptively transferring CD4
Rag1
À/À hosts, the number of donor T cells in the spleen was reduced by more than 40% when Tregs were co-transferred. However, Nfat1 À/À T-cell expansion was not similarly affected ( Fig 1G) .
To confirm the role of NFAT1 in the regulation of the susceptibility of T cells to Tregs, Nfat1 À/À DO11.10 Th1 cells were transduced with retrovirus expressing NFAT1. Positively infected T cells were re-stimulated with APC-OVA in the presence of Tregs. Nfat1 À/À Th1 cells regained susceptibility to Tregs upon restoration of NFAT1 expression (Fig 2A) . Similar results were obtained when cells were transiently transfected with a plasmid expressing NFAT1 (Fig 2B) . Altogether, these results indicated that NFAT1 activity in Th cells is required to effectively respond to Tregs. It is possible, however, that other NFAT proteins might also cooperate with NFAT1 in this program. NFAT4 has been shown to exert a negative control on T-cell responses, and NFAT1/NFAT4-deficient mice present a more severe lymphoproliferative phenotype than NFAT1-deficient mice [15, 16] . Furthermore, cells lacking these two NFAT proteins have also been shown to be resistant to Treg-mediated suppression [17] . Our data show, however, that T cells that lack just NFAT1 show no major alterations in their responses to TCR engagement, while rendering them less susceptible to Treg-mediated suppression.
Suppressed CD4 + T cells upregulate the expression of Ikaros
We and others have previously identified genes that inhibit T-cell activation that are also expressed in an NFAT-dependent manner in tolerized T cells [18] . We showed that the expression of one such gene, Ikaros, was also upregulated (~15-fold) in suppressed Th1 cells (Fig 2C) . The NFAT1 dependence of Ikaros was further confirmed by the inability of Nfat1 À/À T cells to upregulate its expression when activated in the presence of Tregs (Fig. 2D) . Expression of genes that are known to maintain T cells in an unresponsive state suggested the possibility that Tregs might stably suppress effector T cells. In fact, it has been previously reported that Tregs can anergize naïve CD4 + T cells [19] and Tregs have been shown to induce anergy in arthritogenic self-reactive T cells in vivo [20] . To test this hypothesis, DO11.10 Th1 cells were stimulated with APC-OVA in the presence of Tregs for 24 h. Th1 cells were then purified and rested for 4 h before being re-stimulated. Previously suppressed T cells regained responsiveness when re-stimulated in the absence of Tregs (Fig 2E) , indicating that while Treg-induced NFAT-dependent expression of specific genes inhibited T-cell activation, it was not sufficient to induce a long-lasting unresponsive state. Ikaros mediates silencing of Il2 expression in anergic T cells by inducing epigenetic modifications that maintain the Il2 promoter locus in a closed state [21] [22] [23] [24] . We assessed whether those modifications were also induced by Tregs. Our data revealed that the presence of Tregs resulted in a slight deacetylation of the Il2 locus, a much smaller effect than reported in anergic cells [23] (Fig 2F) . It is likely, thus, that additional signals to those transduced by the presence of Tregs might be required to induce a long-lasting, stable state of unresponsiveness in responder T cells. Accordingly, we could not detect upregulation of several other anergy-associated genes (data not shown), suggesting that specific differences in the programs of gene expression activated in anergic and suppressed T cells might determine divergences between these two forms, passive versus dominant, of T-cell tolerance [25] .
Naïve T cells can also be differentiated into Tregs in the periphery when activated in the presence of specific signals and cytokine environments [26] . To assess whether iTregs also rely on NFAT1-mediated mechanisms, WT and Nfat1 À/À Th1 cells were co-cultured with in vitro generated iTregs ( Fig 2G) and stimulated with APC-OVA. Contrary to what we had seen with tTregs, iTregs efficiently suppressed both WT and Nfat1 À/À T cells (Fig 2H) . Interestingly, iTregs could not induce upregulation of Ikaros (Fig 2I) . The mechanisms involved in iTreg-and tTreg-mediated suppression appear, thus, to be different, and the requirement for NFAT1 is likely specific for tTregs.
Early nuclear NFAT1 translocation occurs in T cells stimulated in the presence of Tregs
Expression of anergy-inducing genes occurs in response to the activation of NFAT1 in the absence of its major transcriptional partner in activated T cells, AP-1 [10] . Indeed, specific activation of NFAT using the calcium ionophore, ionomycin, induced a marked upregulation of Ikaros expression, which was prevented when costimulatory pathways were also activated with PMA ( Fig 3A) . We, thus, determined immunofluorescence. NFAT1 remained cytosolic in resting cells but translocated into the nucleus in Th1 cells that had been activated either in the presence or absence of Tregs ( Fig 3C) . As mentioned above, it is NFAT1 in the absence of AP-1 activation that induces the expression of tolerance-associated genes, and immunofluorescence analysis revealed that Tregs also prevented c-Jun phosphorylation in T cells (Fig 3C) . Although Tregs have been shown to inhibit signaling events downstream of the TCR, including the calcium/NFAT pathway [27] , our data show that early after stimulation in the presence of Tregs, T cells can still activate NFAT but show reduced cJun activation. The presence of an active NFAT protein without concomitant activation of AP-1 should allow suppressed T cells to upregulate the NFAT-dependent AP-1-independent expression of Ikaros [10] . It has been shown that Tregs can prevent the expression of B7 proteins on dendritic cells (DCs) to generate costimulation-deficient cells through mechanisms that involve CTLA-4 [6, 28] . To determine whether this mechanism could explain our results, we analyzed the expression of CD80 and CD86 in DCs in suppression reactions and saw that Tregs induced a clear downregulation of CD80 and CD86 (Fig 3D) . Providing direct costimulation using anti-CD28 antibodies resulted in reduced efficacy of Treg-mediated suppression (Fig 3E) . Furthermore, as previously reported [29, 30] , suppression assays in the presence of a blocking anti-CTLA-4 antibody confirmed that blockade of CTLA-4 prevented Treg-mediated suppression ( Fig 3F) ; the blocking antibodies had however no effect on the activity of iTregs (Fig 3G) . Our data do not exclude that signals directly transmitted by Tregs to effector T cells may also mediate the activation of regulatory gene expression. Supporting this possibility, upregulation of Grail was described when naïve T cells were activated just with anti-CD3 antibodies in the presence of Tregs [19] . Also, direct engagement of B7 proteins on effector T cells by CTLA-4 expressed on Tregs has been proposed as a mechanism of suppression [31] .
Ikaros activity is required for optimal Treg-mediated suppression
Ikaros has been shown to inhibit IL-2 expression in CD4 + T cells [21, 22] . Thus, we assessed Ikaros' role in the Treg-mediated suppression of IL-2 expression. Our results showed that Th1 cells transfected with a plasmid expressing a dominant-negative form of Ikaros (IK-DN) mimicked NFAT1-deficient T cells and became more refractory to Tregs (Fig 4A) . Similar results were obtained using CD4 + CD25 À T cells isolated from transgenic mice expressing IK-DN (Fig 4B) . Furthermore, WT Tregs could not suppress wasting induced by the transfer of naïve IK-DN T cells into Rag1 À/À hosts as efficiently as the one caused by transfer of WT T cells (Fig 4C) . These results confirmed that the activity of Ikaros in CD4 + T cells is required for efficient Treg-mediated suppression. While necessary, this, however, may not be the only mechanism that represses Il2 transcription in suppressed T cells. Treg-mediated activation of ICER/CREM complexes in effector T cells has also been shown to participate in the inhibition of IL-2 production [32] . The possibility remains that these complexes may also regulate Treg-mediated suppression by directly modulating NFAT activity in suppressed T cells [33] . Overall, our results show that NFAT1-regulated gene expression is required for efficient Treg-mediated suppression of CD4 + T cells.
These experiments duly correlate NFAT1 activation in suppressed T cells with the expression of T-cell inactivating genes and identify Ikaros as a regulator of suppression that is required for optimal inhibition of T-cell effector function, thereby providing a basis for how Tregs maintain Th cells in a suppressed state.
Materials and Methods
Mice
Strains description is available in Supplementary Methods.
T-cell isolation
CD4
+ and CD4 + CD25 + cells were isolated from the spleen and lymph nodes of mice using magnetic beads coupled to anti-CD4 or anti-CD25 antibodies (Life Technologies). Alternatively, Foxp3 + Tregs were isolated from Foxp3-RFP mice by sorting for CD4 and RFP expression.
In vitro Th1 differentiation CD4 + T cells were differentiated in vitro as previously described [22] . Details in Supplementary Methods. 
Treg expansion
Tregs were stimulated with 0.25 lg/ml immobilized anti-CD3 and anti-CD28 for 24 h and cultured for 1 week in the presence of 200 U/ml murine IL-2 (Cell Signaling).
iTreg generation
Naive CD4 + T cells were stimulated with 0.5 lg/ml immobilized anti-CD3 and anti-CD28 in the presence of IL-2 (50 U/ml) and TGFb-1 (3 ng/ml) (eBioscience) for 1 week.
In vitro suppression assays 
ELISA and immunofluorescence
See Supplementary Methods for detailed description.
Transfection and retroviral infection of T cells
T cells were transfected by electroporation using a nucleofector electroporator (Amaxa). Retrovirus expressing NFAT1 and conferring G418 resistance (from an IRES) were generated using the Phoenix ecotropic packaging cell line (A gift from Dr G. Nolan, Stanford University, CA). Viral supernatants were used to infect T cells by spin infection at a minimal ratio of five virions/cell. Cells were grown for 1 week in 500 lg/ml G418 to allow selection of positively infected T cells.
Semiquantitative real-time PCR (qPCR)
qPCRs were performed as previously described [22] . Detailed description and primer sequences are provided in Supplementary Methods.
Electrophoretic mobility shift assays (EMSA)
Nuclear extracts were prepared from resting, stimulated, or suppressed cells. NFAT-specific oligonucleotides (5 0 -AGCTAGCT-AGGAATATTCCTGGATGATC) were labeled with [ 32 P]ATP and incubated with nuclear extracts (3-5 lg) and 100 ng/ll poly(dI-dC) for 20 min [14] . DNA-protein complexes were resolved in polyacrylamide gel electrophoresis on a 4% non-denaturing gel.
Chromatin immunoprecipitation (ChIP) assays
ChIp assays suppressed and activated Th1 cells were performed as previously described [22] . See Supplementary Methods for detailed description and primer sequences.
Statistical analysis
Statistical analysis was performed using GraphPad Prism (GraphPad Software). Differences between multiple groups were analyzed by one-way ANOVA with a Tukey's post hoc test.
Comparisons between data pairs were analyzed using a paired t-test (two-tail distribution) or a Mann-Whitney test as indicated in each figure.
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